Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro

被引:100
作者
Vannucchi, A. M. [1 ]
Barbui, T. [2 ]
Cervantes, F. [3 ]
Harrison, C. [4 ]
Kiladjian, J. -J. [5 ,6 ]
Kroeger, N. [7 ]
Thiele, J. [8 ]
Buske, C. [9 ]
机构
[1] Univ Florence, Dept Expt & Clin Med, I-50121 Florence, Italy
[2] Osped Papa Giovanni XXIII, Hematol & Fdn Res, Bergamo, Italy
[3] Univ Barcelona, Hosp Clin, IDIBAPS, Dept Hematol, Barcelona, Spain
[4] Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England
[5] Hop St Louis, INSERM CIC1427, Paris, France
[6] Paris Diderot Univ, Paris, France
[7] Univ Hamburg Hosp, Dept Stem Cell Transplantat, Hamburg, Germany
[8] Univ Cologne, D-50931 Cologne, Germany
[9] Univ Hosp Ulm, Inst Expt Canc Res, Comprehens Canc Ctr Ulm, Ulm, Germany
关键词
INTERNATIONAL WORKING GROUP; STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; POST-ESSENTIAL THROMBOCYTHEMIA; PROGNOSTIC SCORING SYSTEM; REVISED RESPONSE CRITERIA; POLYCYTHEMIA-VERA; PRIMARY MYELOFIBROSIS; IWG-MRT; UNIFIED DEFINITION;
D O I
10.1093/annonc/mdv203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:V85 / V99
页数:15
相关论文
共 78 条
[1]   Allogeneic Stem Cell Transplantation for Myelofibrosis with Leukemic Transformation: A Study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation [J].
Alchalby, Haefaa ;
Zabelina, Tatjana ;
Stuebig, Thomas ;
van Biezen, Anja ;
Bornhaeuser, Martin ;
Di Bartolomeo, Paolo ;
Beelen, Dietrich ;
Cahn, Jean Yves ;
Dreger, Peter ;
Schroyens, William ;
de Witte, Theo ;
Olavarria, Eduardo ;
Kroeger, Nicolaus .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) :279-281
[2]   Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera [J].
Alvarez-Larran, Alberto ;
Pereira, Arturo ;
Cervantes, Francisco ;
Arellano-Rodrigo, Eduardo ;
Hernandez-Boluda, Juan-Carlos ;
Ferrer-Marin, Francisca ;
Angona, Anna ;
Gomez, Montse ;
Muina, Begona ;
Guillen, Helga ;
Teruel, Anabel ;
Bellosillo, Beatriz ;
Burgaleta, Carmen ;
Vicente, Vicente ;
Besses, Carles .
BLOOD, 2012, 119 (06) :1363-1369
[3]   Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia [J].
Alvarez-Larran, Alberto ;
Cervantes, Francisco ;
Pereira, Arturo ;
Arellano-Rodrigo, Eduardo ;
Perez-Andreu, Virginia ;
Hernandez-Boluda, Juan-Carlos ;
Ayats, Ramon ;
Salvador, Carlos ;
Muntanola, Ana ;
Bellosillo, Beatriz ;
Vicente, Vicente ;
Hernandez-Nieto, Luis ;
Burgaleta, Carmen ;
Xicoy, Blanca ;
Besses, Carlos .
BLOOD, 2010, 116 (08) :1205-1210
[4]   Outcome of Transplantation for Myelofibrosis [J].
Ballen, Karen K. ;
Shrestha, Smriti ;
Sobocinski, Kathleen A. ;
Zhang, Mei-Jie ;
Bashey, Asad ;
Bolwell, Brian J. ;
Cervantes, Francisco ;
Devine, Steven M. ;
Gale, Robert Peter ;
Gupta, Vikas ;
Hahn, Theresa E. ;
Hogan, William J. ;
Kroeger, Nicolaus ;
Litzow, Mark R. ;
Marks, David I. ;
Maziarz, Richard T. ;
McCarthy, Philip L. ;
Schiller, Gary ;
Schouten, Harry C. ;
Roy, Vivek ;
Wiernik, Peter H. ;
Horowitz, Mary M. ;
Giralt, Sergio A. ;
Arora, Mukta .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (03) :358-367
[5]   Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia [J].
Barbui, T. ;
Thiele, J. ;
Vannucchi, A. M. ;
Tefferi, A. .
LEUKEMIA, 2013, 27 (10) :1953-1958
[6]   Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet [J].
Barbui, Tiziano ;
Barosi, Giovanni ;
Birgegard, Gunnar ;
Cervantes, Francisco ;
Finazzi, Guido ;
Griesshammer, Martin ;
Harrison, Claire ;
Hasselbalch, Hans Carl ;
Hehlmann, Rudiger ;
Hoffman, Ronald ;
Kiladjian, Jean-Jacques ;
Kroeger, Nicolaus ;
Mesa, Ruben ;
McMullin, Mary F. ;
Pardanani, Animesh ;
Passamonti, Francesco ;
Vannucchi, Alessandro M. ;
Reiter, Andreas ;
Silver, Richard T. ;
Verstovsek, Srdan ;
Tefferi, Ayalew .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (06) :761-770
[7]   Thrombosis in primary myelofibrosis: incidence and risk factors [J].
Barbui, Tiziano ;
Carobbio, Alessandra ;
Cervantes, Francisco ;
Vannucchi, Alessandro M. ;
Guglielmelli, Paola ;
Antonioli, Elisabetta ;
Alvarez-Larran, Alberto ;
Rambaldi, Alessandro ;
Finazzi, Guido ;
Barosi, Giovanni .
BLOOD, 2010, 115 (04) :778-782
[8]   Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment [J].
Barosi, G. ;
Mesa, R. A. ;
Thiele, J. ;
Cervantes, F. ;
Campbell, P. J. ;
Verstovsek, S. ;
Dupriez, B. ;
Levine, R. L. ;
Passamonti, F. ;
Gotlib, J. ;
Reilly, J. T. ;
Vannucchi, A. M. ;
Hanson, C. A. ;
Solberg, L. A. ;
Orazi, A. ;
Tefferi, A. .
LEUKEMIA, 2008, 22 (02) :437-438
[9]   A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group [J].
Barosi, G. ;
Besses, C. ;
Birgegard, G. ;
Briere, J. ;
Cervantes, F. ;
Finazzi, G. ;
Gisslinger, H. ;
Griesshammer, M. ;
Gugliotta, L. ;
Harrison, C. ;
Hasselbalch, H. ;
Lengfelder, E. ;
Reilly, J. T. ;
Michiels, J. J. ;
Barbui, T. .
LEUKEMIA, 2007, 21 (02) :277-280
[10]   Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET) [J].
Barosi, G ;
Bordessoule, D ;
Briere, J ;
Cervantes, F ;
Demory, JL ;
Dupriez, B ;
Gisslinger, H ;
Griesshammer, M ;
Hasselbalch, H ;
Kusec, R ;
Le Bousse-Kerdiles, MC ;
Liberato, NL ;
Marchetti, M ;
Reilly, JT ;
Thiele, J .
BLOOD, 2005, 106 (08) :2849-2853